Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy

Epilepsia

Volumn 47, Issue 9, 2006, Pages 1573-1575

  Contin, Manuela ^a,b   Albani, Fiorenzo ^a   Ambrosetto, Giovanni ^a   Avoni, Patrizia ^a   Bisulli, Francesca ^a   Riva, Roberto ^a   Tinuper, Paolo ^a   Baruzzi, Agostino ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Neurology Clinic   (Italy)

Author keywords

Antiepileptic drug interactions; Epilepsy; Hormonal contraceptives; Lamotrigine

Indexed keywords

CONTRACEPTIVE AGENT; DESOGESTREL; DROSPIRENONE; ETHINYLESTRADIOL; ETONOGESTREL; GESTODENE; LAMOTRIGINE; LEVONORGESTREL; NORELGESTROMIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; CONTRACEPTIVES, ORAL, HORMONAL; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG MONITORING; EPILEPSY; FEMALE; HUMANS; MIDDLE AGED; PERIODICITY; PROSPECTIVE STUDIES; TRIAZINES;

EID: 33748684235     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00558.x     Document Type: Article

References (10)

1. Sabers A, Buchholt JM, Uldall P, et al. Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res 2001;47:151-154.
2. Sabers A, Ohman I, Christensen J, et al. Oral contraceptives reduce lamotrigine plasma levels. Neurology 2003;61:570-571.
3. Reimers A, Helde G, Brodtkorb E. Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia 2005;46:1414-1417.
4. Sidhu J, Bulsara S, Job S, et al. A bidirectional pharmacokinetic interaction study of lamotrigine and the combined oral contraceptive pill in healthy subjects. Epilepsia 2004;45(suppl 7):330.
5. Contin M, Balboni M, Callegati E, et al. Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. J Chromatogr B 2005;113-117.
6. Morris RG, Lee MYY, Cleanthous X, et al. Long-term follow-up using higher target range for lamotrigine monitoring. Ther Dug Monit 2004;26:626-632.
7. Dickins M, Chen C. Lamotrigine: chemistry, biotransformation, and pharmacokinetics. In: Levy RH, Mattson RH, Meldrum BS, et al., eds. Antiepileptic Drugs. Philadelphia: Lippincott Williams & Wilkins, 2002:370.
8. Miners JO, Robson RA, Birkett DJ. Influence of sex and oral contraceptives steroids on paracetamol metabolism. Br J Clin Pharmacol 1983;16:503-509.
9. Herzog AG, Farina EL, Blum AS. Serum valproate levels with oral contraceptive use. Epilepsia 2005;46:970-971.
10. Ehmer U, Vogel A, Schutte JK, et al. Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP- glucuronosyltransferase UGT1A4. Hepatology 2004;39:970-977.